Carmustine and Morphine drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Carmustine (carmustine) and Morphine (morphine sulfate). Common drug interactions include bone pain among females and disseminated cryptococcosis among males.

The phase IV clinical study analyzes what interactions people have when they take Carmustine and Morphine. It is created by eHealthMe based on reports of 27 people who take the same drugs from the FDA, and is updated regularly.

What is Carmustine?

Carmustine has active ingredients of carmustine. eHealthMe is studying from 4,562 Carmustine users. Check the latest studies of Carmustine.

What is Morphine?

Morphine has active ingredients of morphine sulfate. It is often used in pain. eHealthMe is studying from 182,913 Morphine users. Check the latest studies of Morphine.

On Jul, 11, 2026

27 people who take Carmustine and Morphine together, and have interactions are studied.

Carmustine and Morphine drug interactions.

What are the common drug interactions of Carmustine and Morphine, by gender? *:

female:

Bone pain
Clostridium difficile colitis (inflammation of colon by clostridium difficile bacteria infection)
Deep vein thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis)
Septic arthritis streptococcal (serious infection of the joints caused by bacteria streptococcal)
Urinary retention (the inability to completely or partially empty the bladder)
Bacteraemia (presence of bacteria in the blood)
Blindness
Body temperature increased
Burning sensation
Capillary leak syndrome (capillary leaks plasma)

male:

Disseminated cryptococcosis (one of the acquired immune deficiency syndrome defining criteria and the most common cause of life threatening meningitis)
Pneumonia
Neurological decompensation (inability of brain to maintain proper function)
Slow speech
Vomiting
Fungal infection
Abdominal pain
Bacillus infection
Bronchopneumonia (inflammation of the lungs, arising in the bronchi or bronchioles)
Chills (felling of cold)

What are the common drug interactions of Carmustine and Morphine, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

Flushing (the warm, red condition of human skin)
Nasal passage irritation
Throat irritation

30-39:

n/a

40-49:

Disseminated cryptococcosis (one of the acquired immune deficiency syndrome defining criteria and the most common cause of life threatening meningitis)
Pneumonia
Infusion related reaction
Septic shock (shock due to blood infection)
Fungal infection
Abdominal pain
Chills (felling of cold)
Cryptococcosis (potentially fatal fungal disease)
Deep vein thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis)
Hyperhidrosis (abnormally increased sweating)

50-59:

Disease progression
Anaemia (lack of blood)
Dehydration (dryness resulting from the removal of water)
Mantle cell lymphoma (cancer of lymphocytes, a type of white blood cell)
Thrombocytopenia (decrease of platelets in blood)
Bacillus infection
Bronchopneumonia (inflammation of the lungs, arising in the bronchi or bronchioles)
Drug ineffective
Haemoglobin decreased
Haemoptysis (blood-stained sputum from the bronchi, larynx, trachea, or lungs)

60+:

Bone pain
Clostridium difficile colitis (inflammation of colon by clostridium difficile bacteria infection)
Lung disorder (lung disease)
Pneumonia pseudomonal (pseudomonas pneumonia is an infection caused by the microbe known as pseudomonas aeruginosa)
Deep vein thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis)
Septic arthritis streptococcal (serious infection of the joints caused by bacteria streptococcal)
Urinary retention (the inability to completely or partially empty the bladder)
Constipation
Decreased appetite
Neurological decompensation (inability of brain to maintain proper function)

What are the existing conditions these people have? *

Non-Hodgkin's Lymphoma (malignant (cancer) cells form in the lymph system): 7 people, 25.93%
Deep Venous Thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis): 5 people, 18.52%
Burkitt Lymphoma (cancer of the lymphatic system): 5 people, 18.52%
Mantle Cell Lymphoma (cancer of lymphocytes, a type of white blood cell): 4 people, 14.81%
Lymph Follicular Hypertrophy (an increase in the size of the lymph node follicles): 3 people, 11.11%
Metastatic Malignant Melanoma (spreadable cancer tumour of melanine): 2 people, 7.41%
Glioblastoma Multiforme (most common and deadliest of malignant primary brain tumours in adults): 2 people, 7.41%
Glioblastoma (most common and most aggressive malignant primary brain tumour in humans): 2 people, 7.41%
Brain Neoplasm Malignant (brain cancer tumour): 2 people, 7.41%

* Approximation only. Some reports may have incomplete information.

Do you take Carmustine and Morphine?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously